Research - Unit of Cancer immunotherapy

The research of the unit is carried out through the following IDIBAPs research groups:

Lines of research

• Therapy with chimeric antigen receptor (CAR) T-cells
• Therapy with tumour-infiltrating lymphocytes (TILs)
• Combinations of adoptive cell immunotherapy with other drugs or strategies (anti-PD-1/PD-L1 antibodies, bispecific antibodies, radiotherapy, etc.)
• Other advanced therapies for cancer treatment